Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T00:55:07.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T21:00:03.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-29T15:48:17.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T03:34:51.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Chronic Spontaneous Urticaria (CSU) and the involvement of Regeneron Pharmaceuticals as a collaborator, while significant details regarding the study's objectives, duration, and inclusion/exclusion criteria have been removed.
    Difference
    16%
    Check dated 2025-04-16T14:22:53.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:11:54.000Z thumbnail image

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.